You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

very-severe-LRTI

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study

Withdrawn
  • COVID-19
    • (no location specified)
    Nov 1, 2022

    Very Severe Malaria Treated by Intravenous Artesunate

    Completed
    • Severe Malaria
    • None (Observational study Group intravenous artesunate)
    • None (Observational study Group intravenous quinine)
    • Le Chesnay, Île-de-France, France
      Fabrice BRUNEEL
    Mar 23, 2022

    Obesity, Morbid Obesity Trial in Milano (VLCKD, r-MedDiet)

    Recruiting
    • Obesity
    • Morbid Obesity
    • VLCKD
    • r-MedDiet
    • Milano, Italy
      Istituto Auxologico Italiano
    Mar 10, 2023

    Lung Disease Chronic Trial in Toronto (exoskeleton assist)

    Recruiting
    • Lung Disease Chronic
    • exoskeleton assist
    • Toronto, Ontario, Canada
      Westpark Health Care Centre
    Apr 17, 2023

    Ichthyosis Inherited Trial in Toulouse (Cutaneous wraps)

    Not yet recruiting
    • Ichthyosis Inherited
    • Cutaneous wraps
    • Toulouse, France
      Toulouse University hospital
    Jul 28, 2023

    Early and Severe Fetal Growth Restriction on Neurodevelopmental

    Enrolling by invitation
    • Severe Intra-uterine Growth Restriction
    • +3 more
      • (no location specified)
      May 18, 2022

      Severity of RSV Infections in Twins

      Completed
      • RSV Infection
      • Bronchiolitis
      • Epidemiology
      • Bron, France
        Hôpital Femme-Mère-Enfant des Hospices Civils de Lyon
      Jul 4, 2022

      COPD Trial in China (Revefenacin 175 mcg in 3 ML Inhalation Solution, Placebo inhalation solution QD)

      Recruiting
      • COPD
      • Revefenacin 175 mcg in 3 ML Inhalation Solution
      • Placebo inhalation solution QD
      • Beijing, Beijing, China
      • +2 more
      Feb 22, 2022

      COPD Trial in Geneva (early palliative care)

      Completed
      • COPD
      • early palliative care
      • Geneva, Switzerland
        University Hospital Geneva
      Oct 31, 2021

      Lung Disease Chronic Trial in Toronto (exoskeleton assist)

      Completed
      • Lung Disease Chronic
      • exoskeleton assist
      • Toronto, Ontario, Canada
        Westpark Health Care Centre
      Apr 27, 2022

      Respiratory Syncytial Virus Infections Trial (Nirsevimab)

      Not yet recruiting
      • Respiratory Syncytial Virus Infections
      • (no location specified)
      Jun 24, 2022

      6-minute Stepper Test and Pulmonary Rehabilitation in Severe to

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • +2 more
      • 2 times : 6-minute stepper test with a rest of 20min between each test.
      • Bois-Guillaume, France
      • +3 more
      Aug 4, 2021

      Restless Legs Syndrome Trial in Italy, Switzerland (D-methadone, Placebo)

      Recruiting
      • Restless Legs Syndrome
      • Milan, Italy
      • +3 more
      Jul 14, 2022

      Dementia, Mood, Behavior Trial in A Coruña (Bright light therapy)

      Completed
      • Dementia
      • +2 more
      • Bright light therapy
      • A Coruña, Spain
        Universidade da Coruña
      Jul 2, 2021

      Infant, Premature, Diseases, Respiratory Distress Syndrome, Newborn, Bronchopulmonary Dysplasia Trial in France (Curosurf, Air)

      Completed
      • Infant, Premature, Diseases
      • +2 more
      • Amiens, France
      • +12 more
      Aug 23, 2022

      Severe/Very Severe COVID-19 Illness Trial (Ruxolitinib)

      No longer available
      • Severe/Very Severe COVID-19 Illness
      • (no location specified)
      Jan 22, 2021

      COPD Trial in Bois-Guillaume (Nasal high flow)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Nasal high flow
      • Bois-Guillaume, France
        ADIR Association
      Mar 16, 2022

      COPD Trial (Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI, Salbutamol 100 mcg Inhaler (2

      Withdrawn
      • Chronic Obstructive Pulmonary Disease
      • Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI
      • Salbutamol 100 mcg Inhaler (2 inhalations) + Ipratropium 20 mcg Inhalation Aerosol (2 inhalations) Free Combination via MDI
      • (no location specified)
      Sep 3, 2021

      Respiratory Syncytial Virus Trial in Worldwide (Nasal swab sampling, Blood sampling, Diary cards)

      Completed
      Has Results
      • Respiratory Syncytial Virus
      • Nasal swab sampling
      • +2 more
      • Oakland, California
      • +22 more
      Nov 2, 2022

      Pulmonary Disease, Chronic Obstructive Trial in China (Tiotropium Respimat® (T1), Tiotropium Handihaler® (T2))

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Tiotropium Respimat® (T1)
      • Tiotropium Handihaler® (T2)
      • Beijing, China
      • +7 more
      Dec 4, 2021

      COPD (COPD) Trial in Germany (BFF, Symbicort Turbuhaler)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease (COPD)
      • BFF
      • Symbicort Turbuhaler
      • Frankfurt/Main, Germany
      • +3 more
      Feb 21, 2022

      COPD (COPD) Trial in Worldwide (BGF MDI HFO 320/14.4/9.6 µg, BGF MDI HFA 320/14.4/9.6 µg)

      Recruiting
      • Chronic Obstructive Pulmonary Disease (COPD)
      • BGF MDI HFO 320/14.4/9.6 μg
      • BGF MDI HFA 320/14.4/9.6 μg
      • Phoenix, Arizona
      • +96 more
      Jan 23, 2023

      COPD, COPD Exacerbation Trial in Shanghai (aerosol inhaled Amikacin Sulfate Injection, conventional therapy)

      Not yet recruiting
      • COPD
      • COPD Exacerbation
      • aerosol inhaled Amikacin Sulfate Injection
      • conventional therapy
      • Shanghai, Shanghai, China
      • +4 more
      Feb 7, 2022

      Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)

      Recruiting
      • Respiratory Syncytial Virus
      • Human Metapneumovirus
      • mRNA-1345
      • +3 more
      • Andalusia, Alabama
      • +72 more
      Feb 15, 2023

      COPD Trial in United States (Revefenacin, Tiotropium, Revefenacin Placebo)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Jasper, Alabama
      • +38 more
      May 4, 2022